4.5 Article

HPV vaccine acceptability among Kenyan women

Journal

VACCINE
Volume 28, Issue 31, Pages 4864-4867

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.05.034

Keywords

HPV; Vaccine; Africa; Kenya; Cervical cancer; Acceptability

Funding

  1. National Cancer Institute, NIH [CA114773-01]
  2. Fogarty International Center [1K01TW008401-01]
  3. University of Nairobi, Illinois, and Manitoba (UNIM)
  4. American Cancer Society [MSRG-06-259-01-CPPB]

Ask authors/readers for more resources

As human papillomavirus (HPV) vaccines become available in less-developed countries, understanding women's attitudes towards HPV vaccines can help guide approaches to immunization programs. We assessed knowledge and interest in prophylactic HPV vaccines among Kenyan women seeking women's health services (N = 147). They knew little about cervical cancer or HPV vaccine. Most women (95%, 95% confidence interval [CI]: 92%, 99%), however, were willing to have their daughters vaccinated with a vaccine that would prevent cervical cancer, with preference for an inexpensive vaccine requiring fewer doses. (C) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available